• PDF: Delivered by email usually within 24 to 48 UK business hours.

Global Prebiotics Industry

Global Prebiotics Industry

This report analyzes the worldwide markets for Prebiotics in Metric Tons and US$ Million. The US market is further analyzed by the following Product Segments: Mannan-Oligosaccharide (MOS), Fructans (Fructo-Oligosaccaride (FOS), & Inulin), and Others.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World.

Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets.

The report profiles 64 companies including major manufacturers of Prebiotic Ingredients/Supplements such as Beghin Meiji, Beneo-Orafti SA, Cargill Inc., Cosucra Groupe Warcoing SA, GTC Nutrition, Royal Cosun, and Sensus. The report also profiles major manufacturers of Prebiotic Food Products such as Abbott Nutrition, Clasado Ltd., FrieslandCampina Domo, Jarrow Formulas, Inc., Roquette America, Inc., and Weetabix Ltd.

Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-2
Quantitative Techniques & Analytics I-3
Product Definitions and Scope of Study I-3
Mannan-Oligosaccharide (MOS) I-3
Fructans I-3
Fructo-Oligosaccaride (FOS) I-4
Inulin I-4
Others I-4


II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW II-1
Current & Future Analysis II-1
Regional Analysis II-1
Developed Markets - Continue to Capitalize on High Health
Consciousness II-1
Developing Nations - An Emerging Frontier for Prebiotics II-2
Major Prebiotics II-2
GOS Begins to Make a Mark in the Prebiotics Market II-2
Synbiotic Products Gaining Interest II-3
Pro/ Pre Biotic Yogurt II-3
Changing Trends in the Pro/Pre-biotic Yogurt Markets II-3
Emergence of Innovative Prebiotic Ingredients II-3
An Overview of Applications of Prebiotics II-3
Applications in Food Industry II-3
Prebiotics in Infant Feed Formula - Beneficial yet Further
Research Required II-4
Animal Feed Sector Attracts Attention II-4
Fructans - the Most Studied Prebiotic in Animal Feed II-4
Beneficial Effects of Fructans in Monogastric Animals II-5
Rising Interest in Prebiotics for Poultry Feed II-5
Mounting Research on New Applications of Prebiotics II-5
Demand for Prebiotic Clinical Nutrition Products to Surge II-6
Factors Propelling Growth II-6
Growing Awareness of Well Balanced Diet on a Global Scale II-6
Food & Beverages Industry: The Fundamental Growth Driver II-7
Functional Foods Market II-7
Novel Marketing Techniques to Boost Prebiotics Market II-8
Technological Advancements Open New Avenues II-8
Challenges to Reckon II-9
Competitive Landscape II-9

2. A PEEK INTO THE PROBIOTICS MARKET II-10
Prebiotics and Probiotics: Two Most Essential Requirements
for Gut Health II-10
Common Goal with Different Approach - Differences between
Probiotics and Prebiotics II-10
Comparison of Essential Characteristics of Probiotics and
Prebiotics in a Gist II-11
Probiotics: A Macro Perspective II-11
Probiotic Transformation II-12
Threat from Genetically Modified Cultures II-13
Current & Future Analysis II-13
Table 1: World Market for Probiotics (2010-2018): Geographic
Regions Ranked by CAGR - US, Asia-Pacific, Latin America,
Middle East, Europe, Canada, and Japan (includes
corresponding Graph/Chart) II-14
Probiotics: Future Directions II-14
Key Trends, Issues and Drivers II-14
Increasing Number of Probiotic Products Grace the Marketplace II-14
Lactose Intolerance Sufferers Provide Fillip to Probiotics
Market II-15
Versatile Applicability Ensures Sunny Prospects for Probiotics II-15
Weight Management II-15
Oral Care II-15
Beauty II-16
Skincare II-16
Companies Vie for New Delivery Technologies to Boost
Probiotics Consumption II-16
Little Bottles Garner More Appeal II-16
Emergence of Probiotic Cereals and Chocolate Bars II-16
Probiotics to Add Zing to Chilled Beverages II-17
Biopolymer Protection Forecast to Augment Probiotic Market II-17
Growing Consumer Awareness II-17
Scientific and Clinical Validation Key to Growth II-18
Culture Wars II-18
Misleading Health Claims Dampen Demand II-18
Formulation and Production of Probiotic Products: Major
Technical Issues II-19
Regulations to Shape Future Market II-19

3. PRODUCT OVERVIEW II-20
Introduction II-20
Commonly Available Prebiotics II-20
Functioning of Prebiotics II-21
Benefits of Prebiotics II-21
Need for Specific Norms and Scientific Validation II-22
Prebiotic Ingredients: Classification II-22
Oligosaccharides II-22
Mannan-oligosaccharides (MOS) II-23
Chicory Fructans II-23
Fructo-Oligosaccharide (FOS) II-24
Inulin: The Widely Used Prebiotic II-24
Galacto-Oligosaccharide (GOS) II-25
Human Milk Oligosaccharides (HMO) II-25
Xylo-oligosaccharide (XOS) II-25
Prebiotics for Infants II-25
Oligosaccharides in Human Milk II-26
Recommended Consumption II-26
Medical Benefits of Prebiotics and Probiotics II-27
Gum Arabic Provides Solution to Constipation II-28

4. PRODUCT INNOVATIONS/INTRODUCTIONS II-29
Kowa Health Care America Launches Two Supplement Products II-29
Vets Plus Unveils Probios® Soft Chews II-29
Standard Process Unveils ProSynbiotic II-29
EIRO Research Introduces EIROPUR II-29
Biotivia Bioceuticals Launches Florativia II-30
Winn-Dixie Unveils Novel Organic Active Yogurt Product Line II-30
VivAgave® Introduces Organic Inulin II-30
Beneo-Orafti Introduces New Prebiotic Ingredient II-30
Sunny Crunch Foods Launches Probiotic Chewy Cereal Bars II-31
NXT Nutritionals Launches SUSTA 50 Packet Boxes II-31
Nestle Expands Juicy Juice Portfolio with ‘Immunity' and ‘
Brain Development' Drinks II-31
Weetabix Introduces Oaty Bars II-31
Jarrow Formulas to Launch Health Products for Children II-32
Jarrow Formulas Launches Jarro-Dophilus® CDS II-32

5. RECENT INDUSTRY ACTIVITY II-33
Ingredion Receives Approval from Health Canada II-33
Fugeia and Nestle Enter into Collaboration II-33
BENEO-Institute Receives Approval from Indian Government II-33
FUGEIA Receives No Objection Letter from FDA II-33
Beneo Orafti Inks Pacts with Spanish Supermarkets and Panama's
Dairy II-34
FrieslandCampina Domo and Warrnambool Cheese & Butter Factory
Enters into Joint Venture II-34
NXT Nutritionals Merges with NXT Nutritionals Holdings II-34
Royal Friesland Foods, Campina Merge to Form Friesland Campina
Domo II-34

6. FOCUS ON SELECT PLAYERS II-35
Major Manufacturers of Prebiotic Ingredients/ Supplements II-35
Beghin Meiji (France) II-35
Beneo-Orafti SA (Belgium) II-35
Cargill, Inc. (US) II-36
Cosucra Groupe Warcoing SA (Belgium) II-36
GTC Nutrition (US) II-37
Royal Cosun (The Netherlands) II-37
Sensus (The Netherlands) II-38
Major Manufacturers of Prebiotic Food Products II-38
Abbott Nutrition (US) II-38
Clasado Ltd. (UK) II-38
FrieslandCampina Domo (The Netherlands) II-39
Jarrow Formulas, Inc. (US) II-40
Roquette America, Inc. (US) II-40
Weetabix Ltd (UK) II-40

7. GLOBAL MARKET PERSPECTIVE II-41
Table 2: World Recent Past, Current & Future Analysis for
Prebiotics by Geographic Region/Country - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan) and Rest of World
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) II-41

Table 3: World Historic Analysis for Prebiotics by Geographic
Region/ Country - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan) and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2004 through 2009 (includes corresponding Graph/Chart) II-42

Table 4: World 15-Year Perspective for Prebiotics by
Geographic Region/ Country - Percentage Breakdown of Dollar
Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan) and Rest of World Markets for Years 2005, 2013 and 2018
(includes corresponding Graph/Chart) II-43


III. MARKET

1. THE UNITED STATES III-1
A.Market Analysis III-1
US- Still a Small Market for Prebiotics III-1
Current & Future Analysis III-1
Value Analysis III-1
Volume Analysis III-1
Market Overview III-2
Inulin Dominates the Market III-2
Factors Driving Growth for Prebiotics III-2
Wide-ranging Applications to Drive Market III-3
Prebiotics Gain Popularity in Functional Food Market III-3
Diet Control Remains the Key Goal for Prebiotics III-3
Brighter Prospects Ahead III-4
Focus Areas for New Entrants III-4
Regulations on Prebiotics III-4
Product Launches III-5
Strategic Corporate Developments III-7
Key Players III-8
B.Market Analytics III-11
Value Analytics III-11
Table 5: US Recent Past, Current & Future Analysis for
Prebiotics by Product Segment - MOS, Fructans (FOS and
Inulin) and Others Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2010 through
2018 (includes corresponding Graph/Chart) III-11

Table 6: US Historic Review for Prebiotics by Product
Segment - MOS, Fructans (FOS and Inulin) and Others Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-12

Table 7: US 15-Year Perspective for Prebiotics by Product
Segment - Percentage Breakdown of Dollar Sales for MOS,
Fructans (FOS and Inulin) and Others Markets for Years
2005, 2013 and 2018 (includes corresponding Graph/Chart) III-13
Volume Analytics III-14
Table 8: US Recent Past, Current & Future Analysis for
Prebiotics by Product Segment - MOS, Fructans (FOS and
Inulin) and Others Markets Independently Analyzed with
Annual Consumption Figures in Metric Tons for Years 2010
through 2018 (includes corresponding Graph/Chart) III-14

Table 9: US Historic Review for Prebiotics by Product
Segment - MOS, Fructans (FOS and Inulin) and Others Markets
Independently Analyzed with Annual Consumption Figures in
Metric Tons for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-15

Table 10: US 15-Year Perspective for Prebiotics by Product
Segment - Percentage Breakdown of Volume Consumption for
MOS, Fructans (FOS and Inulin) and Others Markets for Years
2005, 2013 and 2018 (includes corresponding Graph/Chart) III-16

2. CANADA III-17
A.Market Analysis III-17
Market Overview III-17
Current & Future Analysis III-17
New Guidance Emerges on Use of the Term “Prebiotic(s)” on
Labels of Food Products III-17
Product Launch III-17
Strategic Corporate Development III-18
B.Market Analytics III-18
Table 11: Canadian Recent Past, Current & Future Analysis
for Prebiotics Analyzed with Annual Sales Figures in US$
Million for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-18

Table 12: Canadian Historic Review for Prebiotics Analyzed
with Annual Sales Figures in US$ Million for Years 2004
through 2009 (includes corresponding Graph/Chart) III-19

3. JAPAN III-20
A.Market Analysis III-20
Current & Future Analysis III-20
Introduction III-20
Oligosaccharides Production in Japan III-20
Factors Driving Growth for Prebiotics III-21
Supportive Regulations Drive Growth of Prebiotics III-21
B.Market Analytics III-22
Table 13: Japanese Recent Past, Current & Future Analysis
for Prebiotics Analyzed with Annual Sales Figures in US$
Million for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-22

Table 14: Japanese Historic Review for Prebiotics Analyzed
with Annual Sales Figures in US$ Million for Years 2004
through 2009 (includes corresponding Graph/Chart) III-23

4. EUROPE III-24
A.Market Analysis III-24
Current and Future Analysis III-24
Factors Driving Growth for Prebiotics III-24
Barriers to Growth of Prebiotics market III-24
Consumers Unawareness on Proper Dosages III-24
Inflating Price III-25
Strict Regulatory Norms III-25
Major Products in Prebiotics Market III-25
End-Use Analysis III-25
Prebiotics and Probiotics: A Promising Combination III-26
Research Initiatives III-26
Regulatory Landscape III-26
EFSA Rebuts Health Claims for Prebiotics III-26
Table 15: EFSA Review Opinions on Submitted Proposed
Health Claims on Food Products with Prebiotics and
Probiotics (includes corresponding Graph/Chart) III-27
Nutrition Claims Still Allowed III-27
B.Market Analytics III-28
Value Analytics III-28
Table 16: European Recent Past, Current & Future Analysis
for Prebiotics by Geographic Region/Country - France,
Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-28

Table 17: European Historic Analysis for Prebiotics by
Geographic Region/ Country - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2004 through 2009 (includes corresponding Graph/Chart) III-29

Table 18: European 15-Year Perspective for Prebiotics by
Geographic Region/ Country - Percentage Breakdown of Dollar
Sales for France, Germany, Italy, UK, Spain, Russia and
Rest of Europe Markets for Years 2005, 2013 and 2018
(includes corresponding Graph/Chart) III-30
Volume Analytics III-31
Table 19: European Recent Past, Current & Future Analysis
for Prebiotics Analyzed with Annual Consumption Figures in
Metric Tons for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-31

Table 20: European Historic Review for Prebiotics Analyzed
with Annual Consumption Figures in Metric Tons for Years
2004 through 2009 (includes corresponding Graph/Chart) III-32

4a. FRANCE III-33
A.Market Analysis III-33
Current & Future Analysis III-33
Key Player III-33
B.Market Analytics III-34
Table 21: French Recent Past, Current & Future Analysis for
Prebiotics Analyzed with Annual Sales Figures in US$ Million
for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-34

Table 22: French Historic Review for Prebiotics Analyzed
with Annual Sales Figures in US$ Million for Years 2004
through 2009 (includes corresponding Graph/Chart) III-35

4b. GERMANY III-36
A.Market Analysis III-36
Current & Future Analysis III-36
B.Market Analytics III-36
Table 23: German Recent Past, Current & Future Analysis for
Prebiotics Analyzed with Annual Sales Figures in US$ Million
for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-36

Table 24: German Historic Review for Prebiotics Analyzed
with Annual Sales Figures in US$ Million for Years 2004
through 2009 (includes corresponding Graph/Chart) III-37

4c. ITALY III-38
A.Market Analysis III-38
Current & Future Analysis III-38
B.Market Analytics III-38
Table 25: Italian Recent Past, Current & Future Analysis for
Prebiotics Analyzed with Annual Sales Figures in US$ Million
for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-38

Table 26: Italian Historic Review for Prebiotics Analyzed
with Annual Sales Figures in US$ Million for Years 2004
through 2009 (includes corresponding Graph/Chart) III-39

4d. THE UNITED KINGDOM III-40
A.Market Analysis III-40
Current & Future Analysis III-40
Product Launch III-40
Key Players III-40
B.Market Analytics III-41
Table 27: UK Recent Past, Current & Future Analysis for
Prebiotics Analyzed with Annual Sales Figures in US$ Million
for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-41

Table 28: UK Historic Review for Prebiotics Analyzed with
Annual Sales Figures in US$ Million for Years 2004 through
2009 (includes corresponding Graph/Chart) III-42

4e. SPAIN III-43
A.Market Analysis III-43
Current & Future Analysis III-43
B.Market Analytics III-43
Table 29: Spanish Recent Past, Current & Future Analysis for
Prebiotics Analyzed with Annual Sales Figures in US$ Million
for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-43

Table 30: Spanish Historic Review for Prebiotics Analyzed
with Annual Sales Figures in US$ Million for Years 2004
through 2009 (includes corresponding Graph/Chart) III-44

4f. RUSSIA III-45
A.Market Analysis III-45
Overview III-45
Current & Future Analysis III-45
Inulin: An Emerging market in Russia III-45
Heavy Dependence on Imports - A Setback III-46
B.Market Analytics III-46
Table 31: Russian Recent Past, Current & Future Analysis for
Prebiotics Analyzed with Annual Sales Figures in US$ Million
for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-46

Table 32: Russian Historic Review for Prebiotics Analyzed
with Annual Sales Figures in US$ Million for Years 2004
through 2009 (includes corresponding Graph/Chart) III-47

4g. REST OF EUROPE III-48
A.Market Analysis III-48
Current & Future Analysis III-48
Product Launch III-48
Strategic Corporate Developments III-48
Key Players III-49
B.Market Analytics III-52
Table 33: Rest of Europe Recent Past, Current & Future
Analysis for Prebiotics Analyzed with Annual Sales Figures
in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-52

Table 34: Rest of Europe Historic Review for Prebiotics
Analyzed with Annual Sales Figures in US$ Million for Years
2004 through 2009 (includes corresponding Graph/Chart) III-53

5. ASIA-PACIFIC III-54
A.Market Analysis III-54
GOS Gains Prominence in Asia III-54
Prebiotic Regulatory Scenario in Select Asian Countries III-54
B.Market Analytics III-55
Table 35: Asia-Pacific Recent Past, Current & Future
Analysis for Prebiotics by Geographic Region/Country -
China, India and Rest of Asia-Pacific Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2010 through 2018 (includes corresponding Graph/Chart) III-55

Table 36: Asia-Pacific Historic Analysis for Prebiotics by
Geographic Region/ Country - China, India and Rest of
Asia-Pacific Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2004 through 2009
(includes corresponding Graph/Chart) III-56

Table 37: Asia-Pacific 15-Year Perspective for Prebiotics by
Geographic Region/ Country - Percentage Breakdown of Dollar
Sales for China, India and Rest of Asia-Pacific Markets for
Years 2005, 2013 and 2018 (includes corresponding
Graph/Chart) III-57

5a. CHINA III-58
A.Market Analysis III-58
Prebiotics Market to Surge in China III-58
Recession Hits the Chinese Inulin Industry III-58
B.Market Analytics III-59
Table 38: Chinese Recent Past, Current & Future Analysis for
Prebiotics Analyzed with Annual Sales Figures in US$ Million
for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-59

Table 39: Chinese Historic Review for Prebiotics Analyzed
with Annual Sales Figures in US$ Million for Years 2004
through 2009 (includes corresponding Graph/Chart) III-60

5b. INDIA III-61
A.Market Analysis III-61
A Bird's Eye View of the Indian Health Ingredients Market III-61
Demand for Prebiotics to Surge III-61
Strategic Corporate Development III-61
B.Market Analytics III-62
Table 40: Indian Recent Past, Current & Future Analysis for
Prebiotics Analyzed with Annual Sales Figures in US$ Million
for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-62

Table 41: Indian Historic Review for Prebiotics Analyzed
with Annual Sales Figures in US$ Million for Years 2004
through 2009 (includes corresponding Graph/Chart) III-63

5c. REST OF ASIA-PACIFIC III-64
A.Market Analysis III-64
Current & Future Analysis III-64
Strategic Corporate Development III-64
B.Market Analytics III-65
Table 42: Rest of Asia-Pacific Recent Past, Current & Future
Analysis for Prebiotics Analyzed with Annual Sales Figures
in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-65

Table 43: Rest of Asia-Pacific Historic Review for
Prebiotics Analyzed with Annual Sales Figures in US$ Million
for Years 2004 through 2009 (includes corresponding
Graph/Chart) III-66

6. REST OF WORLD III-67
A.Market Analysis III-67
Current & Future Analysis III-67
Regulatory Stance on Prebiotics in Latin America III-67
B.Market Analytics III-68
Table 44: Rest of World Recent Past, Current & Future
Analysis for Prebiotics Analyzed with Annual Sales Figures
in US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-68

Table 45: Rest of World Historic Review for Prebiotics
Analyzed with Annual Sales Figures in US$ Million for Years
2004 through 2009 (includes corresponding Graph/Chart) III-69


IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 64 (including Divisions/Subsidiaries - 69)

The United States (28)
Canada (1)
Japan (5)
Europe (25)
- F
+44 20 8816 8548

Ask a question about Global Prebiotics Industry

Enter the characters you see in the picture below
Captcha